EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Dual Antiplatelet Therapy Prior to Percutaneous Coronary Intervention for Acute Coronary Syndrome: Prevalence and Outcomes in Contemporary Practice

Shi Hui Goh, Riley Batchelor iD, Diem Dinh, Angela Brennan, Stacey Peters, Dion Stub, Christopher Reid, William Chan, Danny Liew, William Wilson, Jeffrey Lefkovits, VCOR investigators

Catheterization and Cardiovascular Interventions · 2025-07 · 106 (1) · 165-173

DOI: 10.1002/ccd.31520 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 08.04.2025. Verfasst von Shi Hui Goh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Aspirin, Dual Anti-Platelet Therapy, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dual antiplatelet therapy (DAPT) is standard following percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Preloading is the practice of administering both aspirin and a P2Y 12 inhibitor before PCI. DAPT preloading is common practice, however clinical trial evidence demonstrating benefit is lacking.

Aims

This study aimed to examine the prevalence and associated clinical outcomes of DAPT before PCI for ACS in a contemporary population of Australian patients.

Methods

Data on consecutive PCI procedures from patients included in the Victorian Cardiac Outcomes Registry (VCOR) from 2014 to 2021 was collected and stratified by administration of DAPT before PCI versus single, or no, antiplatelet therapy.

Results

In total, 42,453 consecutive PCI procedures for ACS were included. Of these, 33,520 (79%) patients were either preloaded or already on DAPT before PCI. Patients on DAPT were younger (63.9 vs. 65.1, p < 0.001) and generally had fewer comorbidities. Unadjusted outcomes were more favorable with pre‐loading with lower in‐hospital mortality with DAPT (2.6% vs. 5.6%, p < 0.001), and 30‐day cardiovascular mortality (0.3% vs. 0.4%, p = 0.039). 30‐day major adverse cardiovascular events (MACE) (5.5% vs. 8.8%, p < 0.001) was similarly lower in the preloaded group. Major bleeding in hospital was less common in patients on DAPT (1.0% vs. 1.7%, p < 0.001). However, following adjustment for covariates, there was no difference in in‐hospital or 30‐day all‐cause mortality, MACE or stent thrombosis between groups.

Conclusions

DAPT before PCI is common in ACS but not independently associated with improvements in in‐hospital mortality, MACE, or stent thrombosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeAspirinDual Anti-Platelet TherapyPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsAgedFemaleHumansMaleMiddle AgedHemorrhageHospital MortalityPrevalenceRegistriesRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeVictoria

Stichwörter der Autor:innen

acute coronary syndromedual antiplatelet therapyoutcomespercutaneous coronary interventionpreloading

Substanzen

AspirinPlatelet Aggregation InhibitorsPurinergic P2Y Receptor Antagonists

Autor:innen und Institutionen

  • Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia.
  • Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Department of Cardiology, Alfred Health, Melbourne, Victoria, Australia.
  • School of Population Health, Curtin University, Perth, Western Australia, Australia.
  • Department of Cardiology, Western Health, Melbourne, Australia.

ORCID-Profile: Riley Batchelor

Zitieren

APA

Goh, S. H., Batchelor, R., Dinh, D., Brennan, A., Peters, S., Stub, D., Reid, C., Chan, W., Liew, D., Wilson, W., Lefkovits, J., & VCOR investigators (2025). Dual Antiplatelet Therapy Prior to Percutaneous Coronary Intervention for Acute Coronary Syndrome: Prevalence and Outcomes in Contemporary Practice. Catheterization and Cardiovascular Interventions, 106(1), 165-173. https://doi.org/10.1002/ccd.31520

Vancouver

Goh SH, Batchelor R, Dinh D, Brennan A, Peters S, Stub D, et al. Dual Antiplatelet Therapy Prior to Percutaneous Coronary Intervention for Acute Coronary Syndrome: Prevalence and Outcomes in Contemporary Practice. Catheterization and Cardiovascular Interventions. 2025;106(1):165-173. doi:10.1002/ccd.31520

BibTeX
@article{Goh2025,
  author = {Goh, Shi Hui and Batchelor, Riley and Dinh, Diem and Brennan, Angela and Peters, Stacey and Stub, Dion and Reid, Christopher and Chan, William and Liew, Danny and Wilson, William and Lefkovits, Jeffrey and VCOR investigators, VCOR investigators},
  title = {Dual Antiplatelet Therapy Prior to Percutaneous Coronary Intervention for Acute Coronary Syndrome: Prevalence and Outcomes in Contemporary Practice},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  volume = {106},
  number = {1},
  pages = {165--173},
  doi = {10.1002/ccd.31520}
}
Kostenlos starten →